Pharmaceutical Market Access and Drug Safety Act of 2004
Latest action · Jul 14, 2004 Committee on the Judiciary. Hearings held.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 21, 2004
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Market Access and Drug Safety Act of 2004 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions governing the importation of prescription drugs. Requires the Secretary of Health and Human Services to promulgate regulations allowing the importation of prescription drugs by registered exporters or registered importers from Canada within 90 days of passage of this Act and from Australia, European Union countries, Japan, New Zealand, or Switzerland within one year.
Provides for inspection, tracking of drugs, and registration and inspection fees for registered importers and exporters.
Requires manufacturers to: (1) submit a statement to the Secretary explaining each difference between a drug approved and distributed in the United States and a related drug distributed in a foreign country; and (2) submit an application to the Food and Drug Administration (FDA) for approval of a related drug that is distributed in a foreign country if there is no comparable drug already approved in at least half of the permitted countries that can be imported to the United States.
Allows for the immediate importation of prescription drugs for personal use from licensed Canadian pharmacies.
Amends the Clayton Act to prohibit drug manufacturers from preventing importation by engaging in behavior such as charging higher prices or limiting supplies to registered exporters and importers or changing the form of the drug for such purpose.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary of Homeland Security to refuse admission of drugs that violate importation provisions. Allows the destruction of certain violative shipments.
Amends the Controlled Substances Act to repeal the exemption that permitted individuals to import controlled substances for personal medical use.
Cosponsors 31
Members who signed on, in the order they did. Signatures ran from Apr 21, 2004 to Sep 10, 2004; 10 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MI | Debbie Stabenow | Original | Apr 21, 2004 |
| D-MA | Edward M. Kennedy | Original | Apr 21, 2004 |
| R-AZ | John McCain | Original | Apr 21, 2004 |
| R-RI | Lincoln Chafee | Original | Apr 21, 2004 |
| D-AR | Mark L. Pryor | Original | Apr 21, 2004 |
| R-ME | Olympia J. Snowe | Original | Apr 21, 2004 |
| D-WI | Russell D. Feingold | Original | Apr 21, 2004 |
| D-SD | Thomas A. Daschle | Original | Apr 21, 2004 |
| D-SD | Tim Johnson | Original | Apr 21, 2004 |
| R-MS | Trent Lott | Original | Apr 21, 2004 |
| D-FL | Bill Nelson | Apr 22, 2004 | |
| D-NY | Charles E. Schumer | Apr 22, 2004 | |
| D-CA | Dianne Feinstein | Apr 22, 2004 | |
| D-MN | Mark Dayton | Apr 22, 2004 | |
| D-MA | John F. Kerry | Apr 26, 2004 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Apr 21, 2004Hearings May 20, 2004 |
| Senate | Judiciary Committee | Hearings Jul 14, 2004 |
Actions 5
Everything that happened, newest first.
- Jul 14, 2004Committee on the Judiciary. Hearings held.
- May 20, 2004Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 108-470.
- Apr 21, 2004Introduced in Senate
- Apr 21, 2004Sponsor introductory remarks on measure. (CR S4227-4228)
- Apr 21, 2004Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 6
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S10411, S10412 | Byron L. Dorgan D-ND | Oct 5, 2004 |
| Senate | Debate and remarks S9072 | Christopher J. Dodd D-CT | Sep 10, 2004 |
| Senate | Debate and remarks S8932 | Byron L. Dorgan D-ND | Sep 8, 2004 |
| Extensions | Debate and remarks E1516 | Bob Filner D-CA | Jul 22, 2004 |
| Senate | Debate and remarks S8498 | Debbie Stabenow D-MI | Jul 21, 2004 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 108-923 | EXAMINING THE IMPLICATIONS OF DRUG IMPORTATION282 pages | Judiciary Committee | Jul 14, 2004 |
| S. Hrg. 108-470 | IMPORTATION OF PRESCRIPTION DRUGS129 pages | Health, Education, Labor, and Pensions Committee | May 20, 2004 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R44640 | Patents and Prescription Drug Importation Archived | Report | Oct 4, 2016 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
- Short Titles as Introduced
- Pharmaceutical Market Access and Drug Safety Act of 2004
- Popular Titles
- Imports of Prescription Drugs bill
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative fees
- Administrative procedure
- Administrative remedies
- Australia
- Business records
- Canada
- Civil actions and liability
- Commerce
- Consumer education
- Crime and Law Enforcement
- Customs administration
- Defective products
- Department of Health and Human Services
- Directories
- Drug approvals
- Drug industry
- Drugs
- East Asia
- Economics and Public Finance
- Electronic government information
- English language
- Europe
- European Union
- Evidence (Law)
- Export controls
- Exports
- Finance and Financial Sector
- Fines (Penalties)
- Foreign Trade and International Finance
- Government Operations and Politics
- Government paperwork
- Government publicity
- Governmental investigations
- Health
- Health care fraud
- Identification devices
- Import restrictions
- Imports
- Injunctions
- Intellectual property
- Internet
- Japan
- Labeling
- Law
- Licenses
- New Zealand
- Oceania
- Packaging
- Patent infringement
- Pharmacies
- Pharmacists
- Prescription pricing
- Price discrimination
- Product counterfeiting
- Restrictive trade practices
- Science, Technology, Communications
- Standards
- State laws
- Surety and fidelity
- Switzerland
- Translating and interpreting
- Web sites
- Wholesale trade
Text 1
Each version as it was printed, newest first.
- Apr 21, 2004Introduced in Senate
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.